Cita APA (7a ed.)
Dahlberg, S. E., Sandler, A. B., Brahmer, J. R., Schiller, J. H., & Johnson, D. H. (5/21/2009 Supplement Part 1 of 2). Clinical course of advanced non-small cell lung cancer (NSCLC) patients (pts) experiencing hypertension (HTN) during treatment (TX) with bevacizumab (B) in combination with carboplatin (C) and paclitaxel (P) on E4599. Journal of Clinical Oncology, 27, 8042-8043.
Cita Chicago Style (17a ed.)
Dahlberg, S E., A B. Sandler, J R. Brahmer, J H. Schiller, y D H. Johnson. "Clinical Course of Advanced Non-small Cell Lung Cancer (NSCLC) Patients (pts) Experiencing Hypertension (HTN) During Treatment (TX) with Bevacizumab (B) in Combination with Carboplatin (C) and Paclitaxel (P) on E4599." Journal of Clinical Oncology 27 (5/21/2009 Supplement Part 1 of 2): 8042-8043.
Cita MLA (9a ed.)
Dahlberg, S E., et al. "Clinical Course of Advanced Non-small Cell Lung Cancer (NSCLC) Patients (pts) Experiencing Hypertension (HTN) During Treatment (TX) with Bevacizumab (B) in Combination with Carboplatin (C) and Paclitaxel (P) on E4599." Journal of Clinical Oncology, vol. 27, 5/21/2009 Supplement Part 1 of 2, pp. 8042-8043.
Precaución: Estas citas no son 100% exactas.